Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Iodine-131 Stories

2014-03-23 23:00:43

RnRMarketResearch.com adds Latest Report on “Global Radiopharmaceuticals Market Insight” to its store. Dallas, TX (PRWEB) March 23, 2014 “Purchase the report for 20% discount. Offer valid until 31st March 2014″. Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature....

2014-02-03 00:21:05

WOODCLIFF LAKE, N.J., Feb. 2, 2014 /PRNewswire/ -- Eisai Inc. announced today that the Phase 3 SELECT trial (Study 303) of investigational agent lenvatinib met its primary endpoint. Compared to placebo, lenvatinib showed a highly statistically significant improvement in progression free survival (PFS) in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). The preliminary safety analyses showed that the five most common adverse reactions were hypertension,...

2013-07-12 23:20:32

CampingSurvival.com has announced the release of its recent video interview with iodine expert Chuck Fenwick of Medical Corps, a company that specializes in potassium iodine (KI) and potassium iodate (KIO3) supplements. Fulton, NY (PRWEB) July 12, 2013 CampingSurvival.com has announced the release of its recent video interview with iodine expert Chuck Fenwick of Medical Corps, a company that specializes in potassium iodine (KI) and potassium iodate (KIO3) supplements. In the event of a...

2013-04-09 08:30:45

Unique, non-surgical combination therapy works on both hot and cold thyroid nodules FRANKFURT, Germany, April 9, 2013 /PRNewswire/ -- Dr. Hudayi Korkusuz, a radiologist at the Department of Nuclear Medicine, has conducted the first combination treatment of microwave ablation and radiotherapy. (Photo: http://photos.prnewswire.com/prnh/20130409/PH90748 ) Annually in Germany, about 100,000 thyroid operations are performed. In many cases, treatment of nodular goiter has had mixed...

2013-01-24 23:03:32

Animal Emergency and Referral Center's new treatment facility for cats who suffer from hyperthyroid disease is unlike any other in Minnesota. Oakdale, MN (PRWEB) January 24, 2013 Jayde Quigley has owned her cat Freeway for 11 years. Her young sons started calling him “Old Sick Crabby Kitty” in early 2012 because it seemed like he was always vomiting. He´d also lost weight, yet “He was hungry all the time,” Quigley said. “Suddenly he was stealing food all...

2012-11-26 08:25:06

FRANKFURT, Germany, Nov. 26, 2012 /PRNewswire/ -- The Department of Nuclear Medicine at the Frankfurt University Hospital recently became the first European hospital to use microwaves to ablate thyroid nodules. The success of the new treatment comes as great news for the nearly 20 percent of Germans who have one or more thyroid nodules. In those over 65 years of age, nearly every second person is affected by a thyroid disorder. The enlargement of the thyroid node can be very unpleasant...

2012-08-29 02:25:35

SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., Aug. 29, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the New York State Department of Health has issued a license enabling Veracyte's Afirma® Gene Expression Classifier to be offered to patients in the state. The companies also announced that Memorial Sloan-Kettering Cancer Center...

2012-06-21 02:26:15

QUÉBEC CITY, June 21, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues. Data were presented yesterday by Brian H....

2012-06-12 06:26:20

CINCINNATI, June 12, 2012 /PRNewswire-USNewswire/ -- An experimental treatment that combines intense chemotherapy with a radioactive isotope linked to synthesized neurotransmitter is being tested in newly diagnosed cases of high-risk neuroblastoma - a deadly, hard-to-cure childhood cancer. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) The experimental radiopharmaceutical, 131I-MIBG, has already been tested in children with relapsed and resistant neuroblastoma, with...

2012-06-12 11:42:32

An experimental treatment that combines intense chemotherapy with a radioactive isotope linked to synthesized neurotransmitter is being tested in newly diagnosed cases of high-risk neuroblastoma — a deadly, hard-to-cure childhood cancer. The experimental radiopharmaceutical, 131I-MIBG, has already been tested in children with relapsed and resistant neuroblastoma, with encouraging results in reducing tumor size. This has prompted doctors in a new multi-center pilot clinical trial to...